Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US population,Hepatology

当前位置： X-MOL 学术 › Hepatology › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US population
Hepatology ( IF 12.9 ) Pub Date : 2022-08-21 , DOI: 10.1002/hep.32739
Prowpanga Udompap ₁ , Terry M Therneau ₂ , Rachel E Canning ₂ , Joanne T Benson ₂ , Alina M Allen ₁

Affiliation

The American Gastroenterological Association (AGA) recently launched the Clinical Care Pathway for the Risk Stratification and Management of Patients with NAFLD to identify adults with significant fibrosis. We aimed to examine this pathway's performance in the US population.

中文翻译：